Advancing Cancer Research Through Collaboration
Friends of Cancer Research (Friends) is working to accelerate policy change, support groundbreaking science, and deliver new therapies to patients quickly and safely.
About Friends

Who We Are,
What We Drive

Friends of Cancer Research drives collaboration among partners from every healthcare sector to power advances in science, policy, and regulation that speed life-saving treatments to patients.

  • Drug Development
  • Policy Research & Analysis
  • Diagnostic Development
  • Education & Advocacy
Circulating Tumor DNA (ctDNA)
ctDNA to Monitor Treatment Response (ctMoniTR) is a first of its kind partnership led by Friends of Cancer Research (Friends) to answer the question: Do changes in ctDNA reflect response to treatment?
Learn More
Drug Development Dashboard
Friends has created a series of interactive dashboards as a tool to gain data driven insights into the landscape of oncology drug development and FDA drug approvals. The data in these dashboards are compiled from online publicly available data sources and are regularly updated.
Read More
Homologous Recombination Deficiency (HRD)
The Homologous Recombination Deficiency (HRD) Harmonization Project supports the future use of assays that measure the HRD biomarker for treatment decision making. Friends is currently examining sources of variability across HRD tests and identifying opportunities for alignment while proposing solutions to improve agreement in the future.
Learn More
Bringing together patients and their advocates who wish to incorporate their insight into the regulatory process.
Learn More

Our Power of Collaboration

Publications and growing
Breakthrough therapy designations
Approved breakthrough therapies
Active partnerships

Get Involved

Join Friends by supporting our important work speeding lifesaving treatments to patients.